查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2067545

伴隨診斷市場規模、佔有率和趨勢分析報告：按產品/服務、適應症、技術、檢體類型、最終用途、地區和細分市場預測（2026-2033 年）

Companion Diagnostics Market Size, Share & Trends Analysis Report By product And service, By Indication, By Technology, By Sample Type, By End-use, By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格

伴隨診斷市場概述

全球伴隨診斷市場預計到 2025 年價值 95.6 億美元，預計到 2033 年將達到 200.5 億美元，2026 年至 2033 年的複合年成長率為 10.07%。

這一成長是由對精準醫療的需求不斷成長，以及癌症、心血管疾病和自體免疫疾病的盛行率不斷上升所推動的，而這些反過來又增加了對標靶治療的需求。

從標準化治療方案向個人化醫療的轉變持續推動著伴隨診斷市場的擴張。此外，製藥公司正擴大將伴隨診斷整合到藥物開發平臺中，以提高新療法的成功率，這進一步促進了伴隨診斷行業的成長。

診斷技術的快速發展正推動伴隨診斷產業的擴張。次世代定序(NGS)、聚合酵素鏈鎖反應(PCR) 和數位病理學的創新提高了生物標記辨識的準確性和效率。這些技術能夠更快、更準確地檢測基因突變和蛋白質表達，這對制定個人化治療方案至關重要。此外，人工智慧 (AI) 和機器學習 (ML) 正在提升診斷準確性和數據解讀能力，從而支援更明智的臨床決策。隨著醫療機構日益重視提供精準且數據驅動的患者照護，這些先進診斷工具在研究和醫療機構中的廣泛應用也促進了市場成長。

監管支持和有利的報銷政策也促進了市場成長。美國食品藥物管理局(FDA) 和歐洲藥品管理局 (EMA) 等政府機構已製定明確的監管流程，以促進伴隨診斷測試與標靶治療聯合應用的核准。 FDA 批准的伴隨診斷測試數量不斷增加，顯示個人化醫療的接受度日益提高。例如，2024 年 10 月，羅氏宣布其 VENTANA 檢測成為首個獲得美國食品藥物管理局(FDA) 批准的免疫組化 (IHC) 伴隨診斷測試，用於評估胃癌或胃食道交界處腺癌患者腫瘤中 CLDN18 蛋白的表達。此次獲準將使合格的患者能夠接受Astellas的標靶治療VYLOY 的治療。此外，保險報銷政策也在進行調整，以降低這些先進診斷測試的費用，使患者更容易獲得這些測試。隨著監管機構繼續支持藥物和診斷的聯合開發，製藥和生物技術公司正在大力投資開發新的伴隨診斷測試，以提高治療的準確性並提高市場滲透率。

癌症相關疾病的日益普及是推動伴隨診斷產業發展的另一個關鍵因素。癌症仍然是全球主要死因之一，伴隨診斷透過識別基因突變來指導標靶治療的選擇，在癌症治療中發揮至關重要的作用。癌症在21世紀仍然是一項重大的健康挑戰和主要死因。 2025年9月發表在《柳葉刀》上的一項名為「2023年全球疾病負擔（GBD）」的調查評估了1990年至2023年間204個國家和地區47種癌症的疾病負擔，並預測了到2050年的情況。據估計，到2023年，癌症將成為全球第二大死因，僅次於心血管疾病，預計2050年，癌症相關死亡總數將超過1,800萬人。

羅氏診斷、賽默飛世爾科技和凱傑等公司正積極投資多種癌症的伴隨診斷，包括肺癌、乳癌和大腸癌。隨著這些癌症發生率的不斷上升，對早期精準診斷的需求日益成長，醫療專業人員也開始將伴隨診斷融入常規臨床實踐。隨著精準腫瘤學日益受到關注，在改善治療效果和降低醫療成本的需求驅動下，伴隨診斷市場預計將進一步擴大。

目錄

第1章：調查方法和範圍

第2章執行摘要

第3章：伴隨診斷市場：變數、趨勢與範圍

  • 市場概況及未來展望
  • 市場規模和成長前景
  • 市場動態
  • 伴隨診斷市場分析工具

第4章：伴隨診斷市場：按產品和服務分類的估算和趨勢分析

  • 伴隨診斷市場：基於產品/服務的波動分析，2025 年和 2033 年
  • 檢測方法、試劑盒、試劑
  • 設備和系統
  • 軟體和服務

第5章：伴隨診斷市場：依適應症分類的估算與趨勢分析

  • 伴隨診斷市場：基於適應症的波動分析，2025 年和 2033 年
  • 腫瘤學
  • 感染疾病
  • 心血管疾病
  • 神經病變
  • 其他改編

第6章：伴隨診斷市場：依技術分類的估算與趨勢分析

  • 伴隨診斷市場：按樣本類型分類的波動分析（2025 年和 2033 年）
  • 聚合酵素鏈鎖反應（PCR）
  • 次世代定序（NGS）
  • 原位雜合反應（ISH）
  • 免疫組織化學（IHC）
  • 磁振造影（MRI）
  • 其他技術

第7章 伴隨診斷市場：依樣本類型分類的估算與趨勢分析

  • 伴隨診斷市場：按樣本類型分類的波動分析（2025 年和 2033 年）
  • 組織樣本
  • 血液檢體
  • 其他檢體類型

第8章：伴隨診斷市場：依最終用途分類的估算與趨勢分析

  • 伴隨診斷市場：按最終用途分類的波動分析（2025 年和 2033 年）
  • 學術和研究機構
  • 醫院和醫生檢查室
  • CRO
  • 參考實驗室
  • 製藥和生物技術公司
  • 其他用途

第9章：伴隨診斷市場：區域估算與趨勢分析

  • 伴隨診斷市場區域佔有率，2025 年和 2033 年
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • UAE
    • 科威特

第10章 競爭格局

  • 主要市場參與企業的最新趨勢及影響分析
  • 公司分類
  • 企業熱力圖分析
  • 公司簡介
    • QIAGEN
    • Agilent Technologies, Inc.
    • Abbott
    • Thermo Fisher Scientific, Inc.
    • F. Hoffmann La Roche Ltd
    • Foundation Medicine
    • Myriad Genetics
    • Illumina, Inc.
    • BioMerieux
    • Leica Biosystems
    • Guardant Health, Inc.
    • EntroGen, Inc.
Product Code: GVR-4-68040-536-9

Companion Diagnostics Market Summary

The global companion diagnostics market size was estimated at USD 9.56 billion in 2025 and is projected to reach USD 20.05 billion by 2033, growing at a CAGR of 10.07% from 2026 to 2033. Growth is supported by increasing demand for precision medicine and the rising prevalence of cancer, cardiovascular diseases, and autoimmune disorders, which are contributing to the need for targeted therapies.

The transition from a one-size-fits-all treatment approach to personalized medicine continues to support the expansion of the companion diagnostics market. In addition, pharmaceutical companies are increasingly integrating companion diagnostics into drug development pipelines to improve the success rate of novel therapeutics, further contributing to the growth of the companion diagnostics industry.

Rapid advancements in diagnostic technologies are supporting the expansion of the companion diagnostics industry. Innovations in next-generation sequencing (NGS), polymerase chain reaction (PCR), and digital pathology have improved the accuracy and efficiency of biomarker identification. These technologies enable faster and more precise detection of genetic mutations and protein expression, which are essential for personalized treatment decisions. In addition, artificial intelligence (AI) and machine learning (ML) are enhancing diagnostic accuracy and data interpretation, supporting more informed clinical decision-making. The growing adoption of these advanced diagnostic tools across research laboratories and healthcare institutions is contributing to market growth, as providers increasingly focus on delivering precise and data-driven patient care.

Regulatory support and favorable reimbursement policies are also contributing to the market growth. Government agencies such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have established clear regulatory pathways to facilitate the approval of companion diagnostic tests alongside targeted therapies. The increasing number of FDA-approved companion diagnostics is indicative of the growing acceptance of personalized medicine. For instance, in October 2024, Roche announced that its VENTANA Assay had become the first immunohistochemistry (IHC) companion diagnostic approved by the U.S. Food and Drug Administration (FDA) for assessing CLDN18 protein expression in tumors of patients with gastric or gastroesophageal junction adenocarcinoma. This approval enables eligible patients to receive treatment with Astellas' targeted therapy, VYLOY. Additionally, reimbursement policies are evolving to accommodate the cost of these advanced diagnostics, making them more accessible to patients. As regulatory bodies continue to support the co-development of drugs and diagnostics, pharmaceutical and biotech companies are investing heavily in developing new companion diagnostic tests to enhance treatment precision and market penetration.

The rising prevalence of oncology-related diseases is another significant factor driving the growth of the companion diagnostics industry. Cancer remains one of the leading causes of death worldwide, and companion diagnostics play a vital role in oncology treatment by identifying genetic mutations that guide the selection of targeted therapies. Cancer remains a significant health challenge and a leading cause of mortality in the 21st century. According to a study published in The Lancet in September 2025, findings from the Global Burden of Disease (GBD) 2023 study indicate that cancer burden was assessed across 47 cancer types in 204 countries and territories from 1990 to 2023, with projections extending to 2050. Cancer was estimated to be the second leading cause of death globally in 2023, following cardiovascular diseases, with total cancer-related deaths projected to exceed 18 million by 2050.

Companies such as Roche Diagnostics, Thermo Fisher Scientific, and Qiagen are actively investing in companion diagnostics for various cancer types, including lung, breast, and colorectal cancer. The increasing incidence of these cancers has driven a greater demand for early and accurate diagnosis, prompting healthcare providers to integrate companion diagnostics into routine clinical practice. As precision oncology continues to gain traction, the market for companion diagnostics is expected to expand further, driven by the need for better treatment outcomes and reduced healthcare costs.

Global Companion Diagnostics Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global companion diagnostics market report based on product & service, indication, technology, sample type, end use, and region:

  • Product and Service Outlook (Revenue, USD Million, 2021 - 2033)
  • Assays, Kits, & Reagents
  • Instruments and Systems
  • Software and Services
  • Indication Outlook (Revenue, USD Million, 2021 - 2033)
  • Oncology
  • Infectious Diseases
  • Cardiovascular Diseases
  • Neurological Disorders
  • Other Indications
  • Technology Outlook (Revenue, USD Million, 2021 - 2033)
  • Polymerase Chain Reaction (PCR)
  • Next-generation Sequencing (NGS)
  • In-situ Hybridization (ISH)
  • Immunohistochemistry (IHC)
  • Magnetic Resonance Imaging (MRI)
  • Other Technology
  • Sample Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Tissue Samples
  • Blood Samples
  • Other Sample Types
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Academic & Research Centers
  • Hospitals & Physician Laboratories
  • CROs
  • Reference Laboratories
  • Pharmaceutical & Biotechnology Companies
  • Other End-use
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Companion Diagnostics Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Companion Diagnostics Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape
    • 3.4.3. Pipeline
    • 3.4.4. Case Study

Chapter 4. Companion Diagnostics Market: Product and Service Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Companion Diagnostics Market: Product and Service Movement Analysis, 2025 & 2033 (USD Million)
  • 4.3. Assays, Kits, and Reagents
    • 4.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4. Instruments and Systems
    • 4.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Software and Services
    • 4.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Companion Diagnostics Market: Indication Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Companion Diagnostics Market: Indication Movement Analysis, 2025 & 2033 (USD Million)
  • 5.3. Oncology
    • 5.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.4. Infectious Diseases
    • 5.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Cardiovascular Diseases
    • 5.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6. Neurological Disorders
    • 5.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.7. Other Indications
    • 5.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Companion Diagnostics Market: Technology Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Companion Diagnostics Market: Sample Type Movement Analysis, 2025 & 2033 (USD Million)
  • 6.3. Polymerase Chain Reaction (PCR)
    • 6.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.4. Next-generation Sequencing (NGS)
    • 6.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. In-situ Hybridization (ISH)
    • 6.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Immunohistochemistry (IHC)
    • 6.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.7. Magnetic Resonance Imaging (MRI)
    • 6.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.8. Other Technology
    • 6.8.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Companion Diagnostics Market: Sample Type Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Companion Diagnostics Market: Sample Type Movement Analysis, 2025 & 2033 (USD Million)
  • 7.3. Tissue Samples
    • 7.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.4. Blood Samples
    • 7.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5. Other Sample Types
    • 7.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Companion Diagnostics Market: End Use Estimates & Trend Analysis

  • 8.1. Segment Dashboard
  • 8.2. Companion Diagnostics Market: End Use Movement Analysis, 2025 & 2033 (USD Million)
  • 8.3. Academic and Research Centers
    • 8.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4. Hospitals and Physician Laboratories
    • 8.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5. CROs
    • 8.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.6. Reference Laboratories
    • 8.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.7. Pharmaceutical and Biotechnology Companies
    • 8.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.8. Other End-use
    • 8.8.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 9. Companion Diagnostics Market: Regional Estimates & Trend Analysis

  • 9.1. Companion Diagnostics Market Share, By Region, 2025 & 2033 (USD Million)
  • 9.2. North America
    • 9.2.1. North America Companion Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.2.2. U.S.
      • 9.2.2.1. U.S. Companion Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.2.3. Canada
      • 9.2.3.1. Canada Companion Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.2.4. Mexico
      • 9.2.4.1. Mexico Companion Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.3. Europe
    • 9.3.1. Europe Companion Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.3.2. UK
      • 9.3.2.1. UK Companion Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.3.3. Germany
      • 9.3.3.1. Germany Companion Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.3.4. France
      • 9.3.4.1. France Companion Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.3.5. Italy
      • 9.3.5.1. Italy Companion Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.3.6. Spain
      • 9.3.6.1. Spain Companion Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.3.7. Denmark
      • 9.3.7.1. Denmark Companion Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.3.8. Sweden
      • 9.3.8.1. Sweden Companion Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.3.9. Norway
      • 9.3.9.1. Norway Companion Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.4. Asia Pacific
    • 9.4.1. Asia Pacific Companion Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.4.2. Japan
      • 9.4.2.1. Japan Companion Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.4.3. China
      • 9.4.3.1. China Companion Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.4.4. India
      • 9.4.4.1. India Companion Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.4.5. Australia
      • 9.4.5.1. Australia Companion Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.4.6. South Korea
      • 9.4.6.1. South Korea Companion Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.4.7. Thailand
      • 9.4.7.1. Thailand Companion Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.5. Latin America
    • 9.5.1. Latin America Companion Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.5.2. Brazil
      • 9.5.2.1. Brazil Companion Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.5.3. Argentina
      • 9.5.3.1. Argentina Companion Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.6. Middle East and Africa
    • 9.6.1. Middle East and Africa Companion Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.6.2. South Africa
      • 9.6.2.1. South Africa Companion Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.6.3. Saudi Arabia
      • 9.6.3.1. South Africa Companion Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.6.4. UAE
      • 9.6.4.1. UAE Companion Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 9.6.5. Kuwait
      • 9.6.5.1. Kuwait Companion Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Recent Developments & Impact Analysis by Key Market Participants
  • 10.2. Company Categorization
  • 10.3. Company Heat Map Analysis
  • 10.4. Company Profiles
    • 10.4.1. QIAGEN
      • 10.4.1.1. Participant's Overview
      • 10.4.1.2. Financial Performance
      • 10.4.1.3. Product and Service Benchmarking
      • 10.4.1.4. Recent Developments/ Strategic Initiatives
    • 10.4.2. Agilent Technologies, Inc.
      • 10.4.2.1. Participant's Overview
      • 10.4.2.2. Financial Performance
      • 10.4.2.3. Product and Service Benchmarking
      • 10.4.2.4. Recent Developments/ Strategic Initiatives
    • 10.4.3. Abbott
      • 10.4.3.1. Participant's Overview
      • 10.4.3.2. Financial Performance
      • 10.4.3.3. Product and Service Benchmarking
      • 10.4.3.4. Recent Developments/ Strategic Initiatives
    • 10.4.4. Thermo Fisher Scientific, Inc.
      • 10.4.4.1. Participant's Overview
      • 10.4.4.2. Financial Performance
      • 10.4.4.3. Product and Service Benchmarking
      • 10.4.4.4. Recent Developments/ Strategic Initiatives
    • 10.4.5. F. Hoffmann La Roche Ltd
      • 10.4.5.1. Participant's Overview
      • 10.4.5.2. Financial Performance
      • 10.4.5.3. Product and Service Benchmarking
      • 10.4.5.4. Recent Developments/ Strategic Initiatives
    • 10.4.6. Foundation Medicine
      • 10.4.6.1. Participant's Overview
      • 10.4.6.2. Financial Performance
      • 10.4.6.3. Product and Service Benchmarking
      • 10.4.6.4. Recent Developments/ Strategic Initiatives
    • 10.4.7. Myriad Genetics
      • 10.4.7.1. Participant's Overview
      • 10.4.7.2. Financial Performance
      • 10.4.7.3. Product and Service Benchmarking
      • 10.4.7.4. Recent Developments/ Strategic Initiatives
    • 10.4.8. Illumina, Inc.
      • 10.4.8.1. Participant's Overview
      • 10.4.8.2. Financial Performance
      • 10.4.8.3. Product and Service Benchmarking
      • 10.4.8.4. Recent Developments/ Strategic Initiatives
    • 10.4.9. BioMerieux
      • 10.4.9.1. Participant's Overview
      • 10.4.9.2. Financial Performance
      • 10.4.9.3. Product and Service Benchmarking
      • 10.4.9.4. Recent Developments/ Strategic Initiatives
    • 10.4.10. Leica Biosystems
      • 10.4.10.1. Participant's Overview
      • 10.4.10.2. Financial Performance
      • 10.4.10.3. Product and Service Benchmarking
      • 10.4.10.4. Recent Developments/ Strategic Initiatives
    • 10.4.11. Guardant Health, Inc.
      • 10.4.11.1. Participant's Overview
      • 10.4.11.2. Financial Performance
      • 10.4.11.3. Product and Service Benchmarking
      • 10.4.11.4. Recent Developments/ Strategic Initiatives
    • 10.4.12. EntroGen, Inc.
      • 10.4.12.1. Participant's Overview
      • 10.4.12.2. Financial Performance
      • 10.4.12.3. Product and Service Benchmarking
      • 10.4.12.4. Recent Developments/ Strategic Initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 Global companion diagnostics market, by region, 2021 - 2033 (USD Million)
  • Table 3 Global companion diagnostics market, by product and service, 2021 - 2033 (USD Million)
  • Table 4 Global companion diagnostics market, by technology, 2021 - 2033 (USD Million)
  • Table 5 Global companion diagnostics market, by indication, 2021 - 2033 (USD Million)
  • Table 6 Global companion diagnostics market, by sample type, 2021 - 2033 (USD Million)
  • Table 7 Global companion diagnostics market, by end use, 2021 - 2033 (USD Million)
  • Table 8 North America companion diagnostics market, by country, 2021 - 2033 (USD Million)
  • Table 9 North America companion diagnostics market, by product and service, 2021 - 2033 (USD Million)
  • Table 10 North America companion diagnostics market, by indication, 2021 - 2033 (USD Million)
  • Table 11 North America companion diagnostics market, by technology, 2021 - 2033 (USD Million)
  • Table 12 North America companion diagnostics market, by sample type, 2021 - 2033 (USD Million)
  • Table 13 North America companion diagnostics market, by end use, 2021 - 2033 (USD Million)
  • Table 14 U.S. companion diagnostics market, by product and service, 2021 - 2033 (USD Million)
  • Table 15 U.S. companion diagnostics market, by indication, 2021 - 2033 (USD Million)
  • Table 16 U.S. companion diagnostics market, by technology, 2021 - 2033 (USD Million)
  • Table 17 U.S. companion diagnostics market, by sample type, 2021 - 2033 (USD Million)
  • Table 18 U.S. companion diagnostics market, by end use, 2021 - 2033 (USD Million)
  • Table 19 Canada companion diagnostics market, by product and service, 2021 - 2033 (USD Million)
  • Table 20 Canada companion diagnostics market, by indication, 2021 - 2033 (USD Million)
  • Table 21 Canada companion diagnostics market, by technology, 2021 - 2033 (USD Million)
  • Table 22 Canada companion diagnostics market, by sample type, 2021 - 2033 (USD Million)
  • Table 23 Canada companion diagnostics market, by end use, 2021 - 2033 (USD Million)
  • Table 24 Mexico companion diagnostics market, by product and service, 2021 - 2033 (USD Million)
  • Table 25 Mexico companion diagnostics market, by indication, 2021 - 2033 (USD Million)
  • Table 26 Mexico companion diagnostics market, by technology, 2021 - 2033 (USD Million)
  • Table 27 Mexico companion diagnostics market, by sample type, 2021 - 2033 (USD Million)
  • Table 28 Mexico companion diagnostics market, by end use, 2021 - 2033 (USD Million)
  • Table 29 Europe companion diagnostics market, by country, 2021 - 2033 (USD Million)
  • Table 30 Europe companion diagnostics market, by product and service, 2021 - 2033 (USD Million)
  • Table 31 Europe companion diagnostics market, by indication, 2021 - 2033 (USD Million)
  • Table 32 Europe companion diagnostics market, by technology, 2021 - 2033 (USD Million)
  • Table 33 Europe companion diagnostics market, by sample type, 2021 - 2033 (USD Million)
  • Table 34 Europe companion diagnostics market, by end use, 2021 - 2033 (USD Million)
  • Table 35 UK companion diagnostics market, by product and service, 2021 - 2033 (USD Million)
  • Table 36 UK companion diagnostics market, by indication, 2021 - 2033 (USD Million)
  • Table 37 UK companion diagnostics market, by technology, 2021 - 2033 (USD Million)
  • Table 38 UK companion diagnostics market, by sample type, 2021 - 2033 (USD Million)
  • Table 39 UK companion diagnostics market, by end use, 2021 - 2033 (USD Million)
  • Table 40 Germany companion diagnostics market, by product and service, 2021 - 2033 (USD Million)
  • Table 41 Germany companion diagnostics market, by indication, 2021 - 2033 (USD Million)
  • Table 42 Germany companion diagnostics market, by technology, 2021 - 2033 (USD Million)
  • Table 43 Germany companion diagnostics market, by sample type, 2021 - 2033 (USD Million)
  • Table 44 Germany companion diagnostics market, by end use, 2021 - 2033 (USD Million)
  • Table 45 France companion diagnostics market, by product and service, 2021 - 2033 (USD Million)
  • Table 46 France companion diagnostics market, by indication, 2021 - 2033 (USD Million)
  • Table 47 France companion diagnostics market, by technology, 2021 - 2033 (USD Million)
  • Table 48 France companion diagnostics market, by sample type, 2021 - 2033 (USD Million)
  • Table 49 France companion diagnostics market, by end use, 2021 - 2033 (USD Million)
  • Table 50 Italy companion diagnostics market, by product and service, 2021 - 2033 (USD Million)
  • Table 51 Italy companion diagnostics market, by indication, 2021 - 2033 (USD Million)
  • Table 52 Italy companion diagnostics market, by technology, 2021 - 2033 (USD Million)
  • Table 53 Italy companion diagnostics market, by sample type, 2021 - 2033 (USD Million)
  • Table 54 Italy companion diagnostics market, by end use, 2021 - 2033 (USD Million)
  • Table 55 Spain companion diagnostics market, by product and service, 2021 - 2033 (USD Million)
  • Table 56 Spain companion diagnostics market, by indication, 2021 - 2033 (USD Million)
  • Table 57 Spain companion diagnostics market, by technology, 2021 - 2033 (USD Million)
  • Table 58 Spain companion diagnostics market, by sample type, 2021 - 2033 (USD Million)
  • Table 59 Spain companion diagnostics market, by end use, 2021 - 2033 (USD Million)
  • Table 60 Denmark companion diagnostics market, by product and service, 2021 - 2033 (USD Million)
  • Table 61 Denmark companion diagnostics market, by indication, 2021 - 2033 (USD Million)
  • Table 62 Denmark companion diagnostics market, by technology, 2021 - 2033 (USD Million)
  • Table 63 Denmark companion diagnostics market, by sample type, 2021 - 2033 (USD Million)
  • Table 64 Denmark companion diagnostics market, by end use, 2021 - 2033 (USD Million)
  • Table 65 Sweden companion diagnostics market, by product and service, 2021 - 2033 (USD Million)
  • Table 66 Sweden companion diagnostics market, by indication, 2021 - 2033 (USD Million)
  • Table 67 Sweden companion diagnostics market, by technology, 2021 - 2033 (USD Million)
  • Table 68 Sweden companion diagnostics market, by sample type, 2021 - 2033 (USD Million)
  • Table 69 Sweden companion diagnostics market, by end use, 2021 - 2033 (USD Million)
  • Table 70 Norway companion diagnostics market, by product and service, 2021 - 2033 (USD Million)
  • Table 71 Norway companion diagnostics market, by indication, 2021 - 2033 (USD Million)
  • Table 72 Norway companion diagnostics market, by technology, 2021 - 2033 (USD Million)
  • Table 73 Norway companion diagnostics market, by sample type, 2021 - 2033 (USD Million)
  • Table 74 Norway companion diagnostics market, by end use, 2021 - 2033 (USD Million)
  • Table 75 Asia Pacific companion diagnostics market, by country, 2021 - 2033 (USD Million)
  • Table 76 Asia Pacific companion diagnostics market, by product and service, 2021 - 2033 (USD Million)
  • Table 77 Asia Pacific companion diagnostics market, by indication, 2021 - 2033 (USD Million)
  • Table 78 Asia Pacific companion diagnostics market, by technology, 2021 - 2033 (USD Million)
  • Table 79 Asia Pacific companion diagnostics market, by sample type, 2021 - 2033 (USD Million)
  • Table 80 Asia Pacific companion diagnostics market, by end use, 2021 - 2033 (USD Million)
  • Table 81 Japan companion diagnostics market, by product and service, 2021 - 2033 (USD Million)
  • Table 82 Japan companion diagnostics market, by indication, 2021 - 2033 (USD Million)
  • Table 83 Japan companion diagnostics market, by technology, 2021 - 2033 (USD Million)
  • Table 84 Japan companion diagnostics market, by sample type, 2021 - 2033 (USD Million)
  • Table 85 Japan companion diagnostics market, by end use, 2021 - 2033 (USD Million)
  • Table 86 China companion diagnostics market, by product and service, 2021 - 2033 (USD Million)
  • Table 87 China companion diagnostics market, by sample type, 2021 - 2033 (USD Million)
  • Table 88 China companion diagnostics market, by indication, 2021 - 2033 (USD Million)
  • Table 89 China companion diagnostics market, by technology, 2021 - 2033 (USD Million)
  • Table 90 China companion diagnostics market, by end use, 2021 - 2033 (USD Million)
  • Table 91 India companion diagnostics market, by product and service, 2021 - 2033 (USD Million)
  • Table 92 India companion diagnostics market, by indication, 2021 - 2033 (USD Million)
  • Table 93 India companion diagnostics market, by technology, 2021 - 2033 (USD Million)
  • Table 94 India companion diagnostics market, by sample type, 2021 - 2033 (USD Million)
  • Table 95 India companion diagnostics market, by end use, 2021 - 2033 (USD Million)
  • Table 96 Australia companion diagnostics market, by product and service, 2021 - 2033 (USD Million)
  • Table 97 Australia companion diagnostics market, by indication, 2021 - 2033 (USD Million)
  • Table 98 Australia companion diagnostics market, by technology, 2021 - 2033 (USD Million)
  • Table 99 Australia companion diagnostics market, by sample type, 2021 - 2033 (USD Million)
  • Table 100 Australia companion diagnostics market, by end use, 2021 - 2033 (USD Million)
  • Table 101 South Korea companion diagnostics market, by product and service, 2021 - 2033 (USD Million)
  • Table 102 South Korea companion diagnostics market, by indication, 2021 - 2033 (USD Million)
  • Table 103 South Korea companion diagnostics market, by technology, 2021 - 2033 (USD Million)
  • Table 104 South Korea companion diagnostics market, by sample type, 2021 - 2033 (USD Million)
  • Table 105 South Korea companion diagnostics market, by end use, 2021 - 2033 (USD Million)
  • Table 106 Thailand companion diagnostics market, by product and service, 2021 - 2033 (USD Million)
  • Table 107 Thailand companion diagnostics market, by indication, 2021 - 2033 (USD Million)
  • Table 108 Thailand companion diagnostics market, by technology, 2021 - 2033 (USD Million)
  • Table 109 Thailand companion diagnostics market, by sample type, 2021 - 2033 (USD Million)
  • Table 110 Thailand companion diagnostics market, by end use, 2021 - 2033 (USD Million)
  • Table 111 Latin America companion diagnostics market, by country, 2021 - 2033 (USD Million)
  • Table 112 Latin America companion diagnostics market, by product and service, 2021 - 2033 (USD Million)
  • Table 113 Latin America companion diagnostics market, by indication, 2021 - 2033 (USD Million)
  • Table 114 Latin America companion diagnostics market, by technology, 2021 - 2033 (USD Million)
  • Table 115 Latin America companion diagnostics market, by sample type, 2021 - 2033 (USD Million)
  • Table 116 Latin America companion diagnostics market, by end use, 2021 - 2033 (USD Million)
  • Table 117 Brazil companion diagnostics market, by product and service, 2021 - 2033 (USD Million)
  • Table 118 Brazil companion diagnostics market, by indication, 2021 - 2033 (USD Million)
  • Table 119 Brazil companion diagnostics market, by technology, 2021 - 2033 (USD Million)
  • Table 120 Brazil companion diagnostics market, by sample type, 2021 - 2033 (USD Million)
  • Table 121 Brazil companion diagnostics market, by end use, 2021 - 2033 (USD Million)
  • Table 122 Argentina companion diagnostics market, by product and service, 2021 - 2033 (USD Million)
  • Table 123 Argentina companion diagnostics market, by indication, 2021 - 2033 (USD Million)
  • Table 124 Argentina companion diagnostics market, by technology, 2021 - 2033 (USD Million)
  • Table 125 Argentina companion diagnostics market, by sample type, 2021 - 2033 (USD Million)
  • Table 126 Argentina companion diagnostics market, by end use, 2021 - 2033 (USD Million)
  • Table 127 MEA companion diagnostics market, by country, 2021 - 2033 (USD Million)
  • Table 128 MEA companion diagnostics market, by product and service, 2021 - 2033 (USD Million)
  • Table 129 MEA companion diagnostics market, by indication, 2021 - 2033 (USD Million)
  • Table 130 MEA companion diagnostics market, by technology, 2021 - 2033 (USD Million)
  • Table 131 MEA companion diagnostics market, by sample type, 2021 - 2033 (USD Million)
  • Table 132 MEA companion diagnostics market, by end use, 2021 - 2033 (USD Million)
  • Table 133 South Africa companion diagnostics market, by product and service, 2021 - 2033 (USD Million)
  • Table 134 South Africa companion diagnostics market, by indication, 2021 - 2033 (USD Million)
  • Table 135 South Africa companion diagnostics market, by technology, 2021 - 2033 (USD Million)
  • Table 136 South Africa companion diagnostics market, by sample type, 2021 - 2033 (USD Million)
  • Table 137 South Africa companion diagnostics market, by end use, 2021 - 2033 (USD Million)
  • Table 138 Saudi Arabia companion diagnostics market, by product and service, 2021 - 2033 (USD Million)
  • Table 139 Saudi Arabia companion diagnostics market, by indication, 2021 - 2033 (USD Million)
  • Table 140 Saudi Arabia companion diagnostics market, by technology, 2021 - 2033 (USD Million)
  • Table 141 Saudi Arabia companion diagnostics market, by sample type, 2021 - 2033 (USD Million)
  • Table 142 Saudi Arabia companion diagnostics market, by end use, 2021 - 2033 (USD Million)
  • Table 143 UAE companion diagnostics market, by product and service, 2021 - 2033 (USD Million)
  • Table 144 UAE companion diagnostics market, by indication, 2021 - 2033 (USD Million)
  • Table 145 UAE companion diagnostics market, by technology, 2021 - 2033 (USD Million)
  • Table 146 UAE companion diagnostics market, by sample type, 2021 - 2033 (USD Million)
  • Table 147 UAE companion diagnostics market, by end use, 2021 - 2033 (USD Million)
  • Table 148 Kuwait companion diagnostics market, by product and service, 2021 - 2033 (USD Million)
  • Table 149 Kuwait companion diagnostics market, by indication, 2021 - 2033 (USD Million)
  • Table 150 Kuwait companion diagnostics market, by technology, 2021 - 2033 (USD Million)
  • Table 151 Kuwait companion diagnostics market, by sample type, 2021 - 2033 (USD Million)
  • Table 152 Kuwait companion diagnostics market, by end use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Companion Diagnostics market segmentation
  • Fig. 2 Data analysis models
  • Fig. 3 Market formulation and validation
  • Fig. 4 Data validating & publishing
  • Fig. 5 Market research process
  • Fig. 6 Information procurement
  • Fig. 7 Primary research
  • Fig. 8 Value-chain-based sizing & forecasting
  • Fig. 9 QFD modeling for market share assessment
  • Fig. 10 Market formulation & validation
  • Fig. 11 Commodity flow analysis
  • Fig. 12 Market outlook
  • Fig. 13 Segment snapshot-1
  • Fig. 14 Segment snapshot-2
  • Fig. 15 Competitive landscape snapshot
  • Fig. 16 Market trends & outlook
  • Fig. 17 Porter's five forces analysis
  • Fig. 18 PESTEL analysis
  • Fig. 19 Companion Diagnostics market: Product and Service outlook key takeaways
  • Fig. 20 Companion Diagnostics market: Product and Service movement analysis
  • Fig. 21 Assays, kits, and reagents market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 22 Instruments and systems market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 23 Software and services market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 24 Companion Diagnostics market: Indication outlook key takeaways
  • Fig. 25 Companion Diagnostics market: Indication movement analysis
  • Fig. 26 Oncology market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 27 Infectious diseases market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 28 Cardiovascular diseases market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 29 Neurological disorders market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 30 Other Indications market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 31 Companion Diagnostics market: Technology outlook key takeaways
  • Fig. 32 Companion Diagnostics market: Technology movement analysis
  • Fig. 33 Polymerase Chain Reaction (PCR) market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 34 Next-generation Sequencing (NGS) market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 In-situ Hybridization (ISH) market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 36 Immunohistochemistry (IHC) market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 37 Magnetic Resonance Imaging (MRI) market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 38 Other technology market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 39 Companion Diagnostics market: Sample Type outlook key takeaways
  • Fig. 40 Companion Diagnostics market: Sample Type movement analysis
  • Fig. 41 Tissue samples market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 42 Blood samples market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 43 Other sample types market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 44 Companion Diagnostics market: End-use outlook key takeaways
  • Fig. 45 Companion Diagnostics market: End-use movement analysis
  • Fig. 46 Academic and Research Centers
  • Fig. 47 Hospitals and Physician Laboratories market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 48 CROs market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 49 Reference Laboratories market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 50 Pharmaceutical and Biotechnology Companies market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 51 Other End-use market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 52 Regional marketplace outlook, 2025 & 2033 (USD million)
  • Fig. 53 Regional marketplace: Key takeaways
  • Fig. 54 North America companion diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 55 Key country dynamics
  • Fig. 56 U.S. companion diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 57 Key country dynamics
  • Fig. 58 Canada companion diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 59 Key country dynamics
  • Fig. 60 Mexico companion diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 61 Europe companion diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 62 Key country dynamics
  • Fig. 63 UK companion diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 64 Key country dynamics
  • Fig. 65 Germany companion diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 66 Key country dynamics
  • Fig. 67 France companion diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 68 Key country dynamics
  • Fig. 69 Spain companion diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 70 Key country dynamics
  • Fig. 71 Italy companion diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 72 Key country dynamics
  • Fig. 73 Denmark companion diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 74 Key country dynamics
  • Fig. 75 Sweden companion diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 76 Key country dynamics
  • Fig. 77 Norway companion diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 78 Asia Pacific companion diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 79 Key country dynamics
  • Fig. 80 Japan companion diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 81 Key country dynamics
  • Fig. 82 China companion diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 83 Key country dynamics
  • Fig. 84 India companion diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 85 Key country dynamics
  • Fig. 86 Australia companion diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 87 Key country dynamics
  • Fig. 88 South Korea companion diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 89 Key country dynamics
  • Fig. 90 Thailand companion diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 91 Latin America companion diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 92 Key country dynamics
  • Fig. 93 Brazil companion diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 94 Key country dynamics
  • Fig. 95 Argentina companion diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 96 Middle East & Africa companion diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 97 Key country dynamics
  • Fig. 98 South Africa companion diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 99 Key country dynamics
  • Fig. 100 Saudi Arabia companion diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 101 Key country dynamics
  • Fig. 102 UAE companion diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 103 Key country dynamics
  • Fig. 104 Kuwait companion diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 105 Market participant categorization
  • Fig. 106 Companion Diagnostics market position analysis, 2025
  • Fig. 107 Strategic framework